CAR T-cells profiling in carcinogenesis and tumorigenesis: An overview of CAR T-cells cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CAR T-cells profiling in carcinogenesis and tumorigenesis: An overview of CAR T-cells cancer therapy

Published:2021-01 Issue: Volume:90 Page:107201
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Samadani Ali Akbar,Keymoradzdeh Arman,Shams Shima,Soleymanpour Armin,Rashidy-Pour Ali,Hashemian Houman,Vahidi Sogand,Norollahi Seyedeh Elham

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference70 articles.

1. Recent advances in CAR-T cell engineering;Huang;J. Hematol. Oncol.,2020

2. CAR T cell therapy: A game changer in cancer treatment;Almåsbak;J. Immunol. Res.,2016

3. Cellular immunotherapies for cancer;Hayes;Ir. J. Med. Sci. (1971-),2020

4. Design and development of therapies using chimeric antigen receptor-expressing T cells;Dotti;Immunol. Rev.,2014

5. Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T cells;Zhao;Cancer Cell,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of the combination therapy of chemotherapy drugs on the fluctuations of genes involved in the TLR signaling pathway in glioblastoma multiforme therapy;Biomedicine & Pharmacotherapy;2024-08

2. CAR-NK cell therapy in AML: Current treatment, challenges, and advantage;Biomedicine & Pharmacotherapy;2024-08

3. A critical review of the recent concept of regulatory performance of DNA Methylations, and DNA methyltransferase enzymes alongside the induction of immune microenvironment elements in recurrent pregnancy loss;Toxicology Reports;2024-06

4. Therapeutic potential of CRISPR/CAS9 genome modification in T cell-based immunotherapy of cancer;Cytotherapy;2024-05

5. IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside;International Immunopharmacology;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3